ArticleeLife2020

Marked synergy by vertical inhibition of EGFR signaling in NSCLC spheroids shows SOS1 is a therapeutic target in EGFR-mutated cancer.

Patricia L Theard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.